Sinco Pharmaceuticals Holdings Limited

SEHK:6833 Rapport sur les actions

Capitalisation boursière : HK$382.2m

Sinco Pharmaceuticals Holdings Résultats passés

Passé contrôle des critères 4/6

Sinco Pharmaceuticals Holdings a connu une croissance annuelle moyenne de ses bénéfices de 20.1%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en hausse à 11.2% par an. Les revenus ont augmenté de en hausse à un taux moyen de 16.9% par an. Le rendement des capitaux propres de Sinco Pharmaceuticals Holdings est 7.2% et ses marges nettes sont de 1.6%.

Informations clés

20.1%

Taux de croissance des bénéfices

18.5%

Taux de croissance du BPA

Healthcare Croissance de l'industrie11.3%
Taux de croissance des recettes16.9%
Rendement des fonds propres7.2%
Marge nette1.6%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Recent updates

What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Oct 04
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Aug 16
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Ventilation des recettes et des dépenses

Comment Sinco Pharmaceuticals Holdings gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

SEHK:6833 Recettes, dépenses et bénéfices (CNY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 242,977472120
31 Mar 242,758442100
31 Dec 232,540422070
30 Sep 232,386351960
30 Jun 232,232271900
31 Mar 232,252481970
31 Dec 222,272692050
30 Sep 222,289962180
30 Jun 222,3071222320
31 Mar 222,1651282020
31 Dec 212,0241351720
30 Sep 212,1421481370
30 Jun 212,2611611020
31 Mar 212,1551401160
31 Dec 202,0501181300
30 Sep 201,664791500
30 Jun 201,277411700
31 Mar 201,227321660
31 Dec 191,176241620
30 Sep 191,045-972060
30 Jun 19915-2172510
31 Mar 19934-2492880
31 Dec 18953-2813250
30 Sep 18960-2422920
30 Jun 18966-2032580
31 Mar 18886-1952060
31 Dec 17807-1861530
30 Sep 17755-1151150
30 Jun 17704-43770
31 Mar 17781-12750
31 Dec 1685919740
30 Sep 1695836710
30 Jun 161,05752670
31 Mar 161,07661570
31 Dec 151,09670460
30 Sep 151,12077380
30 Jun 151,14484310
31 Mar 151,04777280
31 Dec 1495069240
31 Dec 1353237120

Des revenus de qualité: 6833 a un niveau élevé de bénéfices non monétaires.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de 6833 sont plus élevées que l'année dernière 6833. (1.6%) sont plus élevées que l'année dernière (1.2%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: 6833 est devenue rentable au cours des 5 dernières années, augmentant ses bénéfices de 20.1% par an.

Accélération de la croissance: La croissance des bénéfices de 6833 au cours de l'année écoulée ( 71.8% ) dépasse sa moyenne sur 5 ans ( 20.1% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices 6833 au cours de l'année écoulée ( 71.8% ) a dépassé celle du secteur Healthcare -16.9%.


Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de 6833 ( 7.2% ) est considéré comme faible.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé